Ventures West 6

Epic Games, Inc. is an American video game and software company founded in 1991 and based in Cary, North Carolina. The company is known for creating and developing immersive games for various platforms, including PCs, consoles, mobile devices, and virtual reality systems. In addition to its game development efforts, Epic Games offers its proprietary game engine technology to other developers, facilitating the creation of high-fidelity interactive experiences. The company also operates a game store that empowers developers to publish quality games and 3D content, thereby fostering a vibrant community of creators and gamers alike. Previously known as Epic MegaGames, Inc., the company rebranded to its current name in March 1999.

Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Spectra7 Microsystems Inc. is an analog semiconductor company based in San Jose, California, with operations in Canada and China. The company focuses on providing high-performance solutions that enhance bandwidth, speed, and resolution for consumer electronics. Its product offerings include advanced technologies for virtual reality (VR) and augmented reality (AR), such as the VR7050, which supports lightweight interconnects for gesture recognition, and the AR-Connect, an integrated solution for AR vision systems. Additionally, Spectra7 develops high-bandwidth, low-latency products like DreamWeVR for VR headsets and AR glasses. The company also caters to data center needs with specialized interconnects and consumer interfaces like GaugeChanger and USB 3.1, suitable for ultra-thin laptops, tablets, and mobile devices. Through its innovations, Spectra7 Microsystems aims to facilitate disruptive designs in various connectivity markets.

Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapeutic antibodies to improve treatment for migraine patients in the United States, Australia, and Ireland. The company's lead candidate, eptinezumab, is a monoclonal antibody targeting calcitonin gene-related peptide, currently in late-stage clinical development for migraine prevention. Alder is also developing ALD1910, a preclinical monoclonal antibody aimed at inhibiting pituitary adenylate cyclase-activating polypeptide-38 for similar purposes, and Clazakizumab, which targets the pro-inflammatory cytokine interleukin-6 and has completed two Phase 2b trials. In addition to its product development efforts, Alder engages in strategic collaborations, notably with CSL Limited for advancing clazakizumab as a treatment for solid organ transplant rejection. Incorporated in 2002 and headquartered in Bothell, Washington, Alder operates primarily in the United States, where it generates most of its revenue.

NeurAxon, Inc. is a Canadian company focused on discovering and developing therapeutics for pain management by targeting neuronal nitric oxide synthase. Founded in 2004 and headquartered in Toronto, NeurAxon is advancing a pipeline of oral products aimed at treating various pain conditions, including acute migraine, neuropathic pain, chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. By utilizing selective inhibitors of nitric oxide synthase, the company seeks to provide effective solutions for individuals suffering from these conditions.

Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Switch Materials Inc. specializes in innovative smart window solutions for the automotive industry, catering to original equipment manufacturers (OEMs) and Tier 1 suppliers. Founded in 2007 and located in Burnaby, Canada, the company focuses on developing advanced materials based on proprietary organic molecules that can change their optical properties upon command. This technology enables various applications, including photochromic and electrochromic systems that automatically adjust the tint of sunroofs to minimize heat and glare. Additionally, Switch Materials' expertise extends to molecular electronics and health sciences, with potential uses in optical filters, photochromic inks, and molecular sensors. The company's research and development is conducted in state-of-the-art laboratories and facilities at 4D LABS, a prominent materials science research center affiliated with Simon Fraser University.

Fresco Microchip is a fabless semiconductor company that addresses the challenge of converting analog signals to digital formats, primarily targeting the consumer electronics market. The company integrates three key technologies: next-generation radio frequency (RF), mixed-signal processing, and digital signal processing (DSP). Fresco's innovative approach utilizes Agile Signal Processing (agileSP™) technology to enable universal legacy demodulation in cost-effective CMOS, achieving television-quality video without the inconsistencies often associated with traditional analog methods. By combining digital demodulation with proprietary technologies such as iSAW™ and agileSP™, Fresco Microchip offers a comprehensive hybrid solution that enhances performance and reliability in electronic devices.

QuickPlay Media Inc. is a prominent provider of cloud-based managed service solutions for the distribution of media to IP-connected devices. Founded in 2004 and headquartered in Toronto, Canada, the company specializes in delivering over-the-top (OTT) video services, enabling clients to deploy content across both managed IPTV set-top boxes and unmanaged devices. QuickPlay's OpenVideo platform offers robust capabilities for live streaming, video on demand, and monetization strategies such as dynamic advertisement insertion and personalized content. Additionally, the company supports pay TV services, allowing traditional cable operators to transition to multiscreen solutions across various networks. With facilities in major cities including San Diego, Singapore, Chennai, and Frankfurt, QuickPlay serves a global clientele, including some of the largest communications and media companies.

Zeugma Systems is a privately held company that specializes in telecommunications equipment and applications for broadband service providers. The company offers the Zeugma Services Node, a service delivery router that consolidates extensive computing resources with advanced capacity and awareness of both services and subscribers in a robust, fully redundant system. This innovative equipment enables service providers to swiftly prototype and launch new revenue-generating services, monitor session flows at a granular level, and manage individual session flows to enforce quality of service policies. Additionally, Zeugma Systems provides Zeugma OSS for configuration and health management of their systems, and Smart Series Applications, which enhance various services like video on demand and voice over IP. Their solutions also support usage-based billing frameworks, reducing the need for multiple edge devices while facilitating standard broadband aggregation and subscriber management functions.

MacroGenics, Inc. is a biopharmaceutical company based in Rockville, Maryland, specializing in the discovery and development of antibody-based therapeutics for cancer treatment. Founded in 2000, the company focuses on immuno-oncology and has a diverse pipeline of product candidates. Key developments include Margetuximab, a monoclonal antibody in Phase III clinical trials targeting HER2-expressing tumors, and Flotetuzumab, a DART molecule aimed at treating acute myeloid leukemia. Other investigational products include MGA012, MGD013, MGD019, and Enoblituzumab, which target various immune checkpoints and tumor-associated antigens. MacroGenics is also advancing combination therapies and antibody-drug conjugates, such as MGC018, which targets solid tumors expressing B7-H3. The company has formed strategic collaborations with notable partners, enhancing its research and development efforts in the biopharmaceutical landscape.

Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Fresco Microchip is a fabless semiconductor company that addresses the challenge of converting analog signals to digital formats, primarily targeting the consumer electronics market. The company integrates three key technologies: next-generation radio frequency (RF), mixed-signal processing, and digital signal processing (DSP). Fresco's innovative approach utilizes Agile Signal Processing (agileSP™) technology to enable universal legacy demodulation in cost-effective CMOS, achieving television-quality video without the inconsistencies often associated with traditional analog methods. By combining digital demodulation with proprietary technologies such as iSAW™ and agileSP™, Fresco Microchip offers a comprehensive hybrid solution that enhances performance and reliability in electronic devices.

BelAir Networks specializes in providing advanced wireless networking equipment that is utilized by major service providers such as AT&T, Comcast, and Time Warner Cable. The company's offerings include indoor access points, outdoor picocell base stations, and comprehensive control and management systems, all designed to enable the deployment of high-performance, scalable, and flexible wireless networks. These solutions are particularly valuable for service providers looking to capitalize on the rapid growth of mobile data usage and applications. BelAir Networks also focuses on high-performance video surveillance networks, enterprise WLAN, and public Wi-Fi hotspots, utilizing a patented switched mesh architecture to ensure reliability and flexibility. Founded in 2002 and privately held, the company has garnered support from investment entities including Comcast Interactive Capital and T-Mobile Venture Fund.

Viigo is a company that specializes in content mobilization, providing a platform that aggregates various types of information for users. Its offerings include modules for news, insights, and blogs, as well as weather updates and sports event information, allowing users to stay informed about current events and forecasts. Additionally, Viigo features a business and finance module that enables users to create and manage their own stock portfolios, track exchange rates, and oversee their online financial accounts. Since 2012, Viigo has also supported small business startups by offering multiple grants each year, contributing to the entrepreneurial ecosystem.

Zeugma Systems is a privately held company that specializes in telecommunications equipment and applications for broadband service providers. The company offers the Zeugma Services Node, a service delivery router that consolidates extensive computing resources with advanced capacity and awareness of both services and subscribers in a robust, fully redundant system. This innovative equipment enables service providers to swiftly prototype and launch new revenue-generating services, monitor session flows at a granular level, and manage individual session flows to enforce quality of service policies. Additionally, Zeugma Systems provides Zeugma OSS for configuration and health management of their systems, and Smart Series Applications, which enhance various services like video on demand and voice over IP. Their solutions also support usage-based billing frameworks, reducing the need for multiple edge devices while facilitating standard broadband aggregation and subscriber management functions.

Sixtron Enterprises Inc. specializes in the development of anti-reflective coating solutions for the solar cell industry, with a particular focus on c-Si solar cell production lines. The company's flagship product, SunBox, is a gas handling solution designed to enhance the efficiency of solar cell manufacturing. In addition to its work in the solar sector, Sixtron is advancing thin film coating solutions applicable to the electronics and industrial coatings industries. These thin films are notable for their unique optical and mechanical properties and can be deposited without the complex requirements associated with hazardous silane gas. Founded in 2004 and based in Calgary, Canada, Sixtron Enterprises Inc. was previously known as SiXtron Advanced Materials Inc.

QuickPlay Media Inc. is a prominent provider of cloud-based managed service solutions for the distribution of media to IP-connected devices. Founded in 2004 and headquartered in Toronto, Canada, the company specializes in delivering over-the-top (OTT) video services, enabling clients to deploy content across both managed IPTV set-top boxes and unmanaged devices. QuickPlay's OpenVideo platform offers robust capabilities for live streaming, video on demand, and monetization strategies such as dynamic advertisement insertion and personalized content. Additionally, the company supports pay TV services, allowing traditional cable operators to transition to multiscreen solutions across various networks. With facilities in major cities including San Diego, Singapore, Chennai, and Frankfurt, QuickPlay serves a global clientele, including some of the largest communications and media companies.

Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company based in San Francisco, California, dedicated to the discovery and development of small-molecule antiviral therapeutics. Founded in 2006, the company primarily focuses on creating therapies for viral infections, with a significant emphasis on hepatitis C virus (HCV) and HIV. Its product portfolio features pan-genotypic HCV NS5A inhibitors and ravidasvir hydrochloride, which target the NS5A and NS5B proteins of HCV. Presidio's antiviral therapeutics are designed for daily oral dosing and can be combined with other antiviral classes to address viral resistance, thus providing patients with effective treatment options against various hepatitis genotypes. The company has raised over $27 million from several investors to support its research and development efforts.

NeurAxon, Inc. is a Canadian company focused on discovering and developing therapeutics for pain management by targeting neuronal nitric oxide synthase. Founded in 2004 and headquartered in Toronto, NeurAxon is advancing a pipeline of oral products aimed at treating various pain conditions, including acute migraine, neuropathic pain, chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. By utilizing selective inhibitors of nitric oxide synthase, the company seeks to provide effective solutions for individuals suffering from these conditions.

Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

6N Silicon, Inc. is a manufacturer of solar grade silicon and polysilicon, primarily serving the photovoltaic industry in North America, Europe, and Asia. Founded in 2006 and based in Vaughan, Canada, the company has developed an innovative low-temperature purification process that utilizes aluminum as a metal solvent to convert metallurgical grade silicon into high-purity solar grade silicon. This process enhances the production of solar cells, contributing to advancements in solar technology. As of 2010, 6N Silicon operates as a wholly owned subsidiary of CaliSolar, Inc.

Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Like most other players in this space, EQO helps save you money on long distance calls by bridging long distance calls over cheaper IP lines. What essentially happens is that your phone an EQO server on a local number, which transfers your call onto cheaper data lines across the internet, and then hops back onto standard phone lines and through another local number to the callee. The call only costs you minutes from your phone plan and the data cost for the VOIP line which runs 95-98% less than standard calling rates. Callers will store value for phone calls in EQO credits. However, calling another EQO user is free.

RapidMind, Inc. is a software development company based in Waterloo, Canada, founded in 2004. It specializes in providing a platform that enables software vendors to optimize performance on multi-core and stream processors, including GPUs. The company's primary offering, the RapidMind Multi-core Development Platform, helps software organizations reduce risk and lower development costs by facilitating the creation of applications that effectively utilize multi-core processing capabilities. In 2006, the company changed its name from Serious Hack, Inc. In August 2009, RapidMind's team and technology were acquired by Intel Corporation, where they continued their work on related products and technology under the "Ct Technology" project.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

Osprey Pharmaceuticals USA, Inc. is a clinical-stage biotechnology company based in San Francisco, California, that specializes in developing protein therapeutics aimed at treating inflammatory and immune diseases. Founded in 2008, the company focuses on a pipeline of proprietary fusion protein therapeutics known as Leukocyte Population Modulators (LPMs). These therapeutics are designed to selectively target and neutralize chemokine-activated leukocytes, which play a crucial role in various inflammatory conditions. Osprey's lead candidate, CCL2-LPM, specifically targets the CCR2 chemokine receptor found on pathologically activated leukocytes and is currently undergoing a Phase Ib clinical trial for the treatment of IgA nephropathy, an inflammatory kidney disease.

BelAir Networks specializes in providing advanced wireless networking equipment that is utilized by major service providers such as AT&T, Comcast, and Time Warner Cable. The company's offerings include indoor access points, outdoor picocell base stations, and comprehensive control and management systems, all designed to enable the deployment of high-performance, scalable, and flexible wireless networks. These solutions are particularly valuable for service providers looking to capitalize on the rapid growth of mobile data usage and applications. BelAir Networks also focuses on high-performance video surveillance networks, enterprise WLAN, and public Wi-Fi hotspots, utilizing a patented switched mesh architecture to ensure reliability and flexibility. Founded in 2002 and privately held, the company has garnered support from investment entities including Comcast Interactive Capital and T-Mobile Venture Fund.

Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapeutic antibodies to improve treatment for migraine patients in the United States, Australia, and Ireland. The company's lead candidate, eptinezumab, is a monoclonal antibody targeting calcitonin gene-related peptide, currently in late-stage clinical development for migraine prevention. Alder is also developing ALD1910, a preclinical monoclonal antibody aimed at inhibiting pituitary adenylate cyclase-activating polypeptide-38 for similar purposes, and Clazakizumab, which targets the pro-inflammatory cytokine interleukin-6 and has completed two Phase 2b trials. In addition to its product development efforts, Alder engages in strategic collaborations, notably with CSL Limited for advancing clazakizumab as a treatment for solid organ transplant rejection. Incorporated in 2002 and headquartered in Bothell, Washington, Alder operates primarily in the United States, where it generates most of its revenue.

DabbleDB lets users build multiple database applications from a single database or spreadsheet. All users have to do is create a single database on DabbleDB and they can create multiple database applications like charts, maps and calendars. The product helps to leverage a single data source to do more work for you.

Zeugma Systems is a privately held company that specializes in telecommunications equipment and applications for broadband service providers. The company offers the Zeugma Services Node, a service delivery router that consolidates extensive computing resources with advanced capacity and awareness of both services and subscribers in a robust, fully redundant system. This innovative equipment enables service providers to swiftly prototype and launch new revenue-generating services, monitor session flows at a granular level, and manage individual session flows to enforce quality of service policies. Additionally, Zeugma Systems provides Zeugma OSS for configuration and health management of their systems, and Smart Series Applications, which enhance various services like video on demand and voice over IP. Their solutions also support usage-based billing frameworks, reducing the need for multiple edge devices while facilitating standard broadband aggregation and subscriber management functions.

MacroGenics, Inc. is a biopharmaceutical company based in Rockville, Maryland, specializing in the discovery and development of antibody-based therapeutics for cancer treatment. Founded in 2000, the company focuses on immuno-oncology and has a diverse pipeline of product candidates. Key developments include Margetuximab, a monoclonal antibody in Phase III clinical trials targeting HER2-expressing tumors, and Flotetuzumab, a DART molecule aimed at treating acute myeloid leukemia. Other investigational products include MGA012, MGD013, MGD019, and Enoblituzumab, which target various immune checkpoints and tumor-associated antigens. MacroGenics is also advancing combination therapies and antibody-drug conjugates, such as MGC018, which targets solid tumors expressing B7-H3. The company has formed strategic collaborations with notable partners, enhancing its research and development efforts in the biopharmaceutical landscape.

Marqui is a cloud-based platform designed for marketing teams to efficiently create, update, and manage website content without requiring coding skills. The platform facilitates the production and publication of web-ready HTML, CSS, and Javascript content, enabling users to control content creation, scheduling, and publication from a single interface. Marqui enhances user experience through its streamlined workflow controls, ensuring an intuitive and organized approach to content management. Additionally, the company offers in-house services to assist teams in designing and developing websites and marketing campaigns. Their Client Success Team provides real-time support to address inquiries and maintain smooth day-to-day operations, further enhancing the overall user experience.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

Avokia, Inc. provides database middleware software for enterprises and customers that enables the continuous availability of database information. It offers apLive, a database and operating system, which allows database clustering by supporting transaction replication in multiple horizontally scaled databases. The company offers its products for enterprise applications for disaster recovery at the database level. Avokia, Inc. was founded in 2000 and is headquartered in Toronto, Canada.

QuIC Financial Technologies, Inc. specializes in developing simulation, risk calculation, and pricing platform solutions tailored for financial institutions and companies. The firm's QuIC product suite features an n-dimensional vector-based calculator designed to solve complex mathematical problems. Key products include the QuIC Engine, which delivers supercomputer-level performance on desktop computers, and QuIC Script, a vector computing language for formulating financial solutions. QuIC Analytics offers a range of instruments covering interest rate and foreign exchange derivatives, equities, commodities, hybrids, asset-backed securities, and credit derivatives, along with various utility function libraries. Additionally, QuIC provides the QuIC Workbench for developing and visualizing QuIC Script, as well as the QuIC Simulation Framework for enterprise-scale portfolio simulation. Integration products such as QuIC Dispatch and QuIC Bridge facilitate seamless connections with client solutions and existing models. The company also offers support services, system integration, custom development, and training resources. Headquartered in Vancouver, Canada, QuIC Financial Technologies operates additional offices in London and New York.

Like most other players in this space, EQO helps save you money on long distance calls by bridging long distance calls over cheaper IP lines. What essentially happens is that your phone an EQO server on a local number, which transfers your call onto cheaper data lines across the internet, and then hops back onto standard phone lines and through another local number to the callee. The call only costs you minutes from your phone plan and the data cost for the VOIP line which runs 95-98% less than standard calling rates. Callers will store value for phone calls in EQO credits. However, calling another EQO user is free.

Resonant Medical is a company that develops, manufactures, and commercializes 3D ultrasound image-guided adaptive radiotherapy products aimed at improving radiation therapy for cancer patients. Its product offerings include the Clarity Breast System, which provides non-ionizing guidance for breast treatments; the Clarity Prostate System, designed for precise non-invasive guidance in prostate cancer treatments; and the Multi-Anatomy System, which facilitates image-guided treatments for various soft tissue anatomies, including gynecological and bladder applications. Established in 2000 and headquartered in Montreal, Canada, Resonant Medical serves a diverse range of healthcare professionals, including physicians, physicists, and therapists. The company's innovative platform enhances radiation therapy planning, verification, and delivery, ensuring advanced care without the use of radiation, thus addressing critical clinical needs in cancer treatment.

Fortiva provides an on-demand email archiving solution that addresses three key challenges – email storage management, legal discovery and regulatory compliance – without the headaches of managing an archive in-house. As a Software as a Service (SaaS) solution, the Fortiva Archiving Suite™ can be up and running in days, with minimal upfront capital costs and planning requirements.

Fresco Microchip is a fabless semiconductor company that addresses the challenge of converting analog signals to digital formats, primarily targeting the consumer electronics market. The company integrates three key technologies: next-generation radio frequency (RF), mixed-signal processing, and digital signal processing (DSP). Fresco's innovative approach utilizes Agile Signal Processing (agileSP™) technology to enable universal legacy demodulation in cost-effective CMOS, achieving television-quality video without the inconsistencies often associated with traditional analog methods. By combining digital demodulation with proprietary technologies such as iSAW™ and agileSP™, Fresco Microchip offers a comprehensive hybrid solution that enhances performance and reliability in electronic devices.

Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapeutic antibodies to improve treatment for migraine patients in the United States, Australia, and Ireland. The company's lead candidate, eptinezumab, is a monoclonal antibody targeting calcitonin gene-related peptide, currently in late-stage clinical development for migraine prevention. Alder is also developing ALD1910, a preclinical monoclonal antibody aimed at inhibiting pituitary adenylate cyclase-activating polypeptide-38 for similar purposes, and Clazakizumab, which targets the pro-inflammatory cytokine interleukin-6 and has completed two Phase 2b trials. In addition to its product development efforts, Alder engages in strategic collaborations, notably with CSL Limited for advancing clazakizumab as a treatment for solid organ transplant rejection. Incorporated in 2002 and headquartered in Bothell, Washington, Alder operates primarily in the United States, where it generates most of its revenue.

Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

TimeSpring has developed a better way to protect data. With TimeSpring protecting your data is simple and automatic; data is always available and instantly recoverable. TimeSpring believes that businesses prefer to focus on their core expertise and their clients, not on the next backup. To accomplish this, TimeSpring gives computers an everlasting memory to ensure data is 100% available, infinitely preserved, and never overwritten.

NeurAxon, Inc. is a Canadian company focused on discovering and developing therapeutics for pain management by targeting neuronal nitric oxide synthase. Founded in 2004 and headquartered in Toronto, NeurAxon is advancing a pipeline of oral products aimed at treating various pain conditions, including acute migraine, neuropathic pain, chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. By utilizing selective inhibitors of nitric oxide synthase, the company seeks to provide effective solutions for individuals suffering from these conditions.

PolyFuel, Inc. is a company that designs, develops, engineers, and manufactures portable fuel cells aimed at enhancing the performance of electronic devices. Founded in 1999 and headquartered in Mountain View, California, PolyFuel focuses on creating advanced membranes and systems to address the power deficiencies in portable electronics. The company's innovations are intended to improve the efficiency and functionality of electronic-based products, catering to the growing demand for reliable and sustainable power solutions.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

Photonics Control delivers sophisticated, intelligent and cost-effective solutions across a whole range of optical devices.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

SiberCore Technologies Incorporated is a pure-play, Internet IC company developing high-value-added Application Specific Standard Products (ASSPs) for intelligent hardware-based switching and routing platforms, such as Gigabit / Terabit Routers and Layer 2 / 3 / 4 Ethernet Switches. The company's initial products are a family of high-speed high-capacity packet forwarding engines based on Content Addressable Memories (CAM technology) which overcome the performance bottleneck associated with the network's routing table look-up function. This emerging market has been created by the demands of the explosion in datacom traffic, coupled with the worldwide deployment of fiber optics and DWDM. These broadband deployments have shifted the bottleneck from the Access and Transport section of the network, to the Routers and Switches connecting to these pipes. The company's founding technical team gained industry-wide recognition for its world-class design expertise in this area at Nortel Networks. A veteran Executive team in all the functional divisions of the company supplements this preeminent technical team.

PolyFuel, Inc. is a company that designs, develops, engineers, and manufactures portable fuel cells aimed at enhancing the performance of electronic devices. Founded in 1999 and headquartered in Mountain View, California, PolyFuel focuses on creating advanced membranes and systems to address the power deficiencies in portable electronics. The company's innovations are intended to improve the efficiency and functionality of electronic-based products, catering to the growing demand for reliable and sustainable power solutions.

Angstrom Power Incorporated researches and develops portable fuel cell devices. It provides Micro Hydrogen, an electrochemical energy converter that produces electricity, water vapor, and heat from hydrogen and airborne oxygen.

Interomex Biopharmaceuticals Inc. is dedicated to the identification of novel biological targets in key cellular processes with the aim of discovering lead compounds for the treatment of disease. The company’s proprietary Repressed Trans-activator (RTATM) technology can be used to detect protein-protein interactions between a host and an infectious agent, as well as within cells in normal and diseased states. A particular advantage of RTATM is its ability to detect the interactions of transcription transactivator proteins, which are key control points in viral infections and cell activation.

Convera is a prominent provider of payment services that specializes in facilitating business-to-business foreign exchange and cross-border payments across various sectors, including education, finance, travel, and healthcare. The company offers a comprehensive payments platform designed to help businesses manage international transactions efficiently and effectively. With a focus on delivering reliable and secure payment solutions, Convera enables users to navigate the complexities of cross-currency payments. In addition to its payment services, Convera also provides enterprise search and categorization solutions through its RetrievalWare technology, which allows organizations to efficiently access and manage vast amounts of unstructured information in multiple formats and languages. This dual focus on payments and information retrieval positions Convera as a valuable partner for organizations seeking to optimize their financial and data management processes.

Plazmic K.K. is a Japanese subsidiary of a Canadian company that specializes in content deployment solutions for mobile devices globally. The company offers a suite of software solutions that facilitate the creation and distribution of rich and dynamic content tailored for wireless devices. Founded by Jay Steele, who served as the Chief Technology Officer and President, Plazmic experienced significant growth and development prior to its acquisition by BlackBerry. At the time of acquisition, it had approximately 36 employees, primarily based in Toronto with an additional team in Tokyo. The company attracted investments totaling around $8 million from various sources, including venture capital firms and angel investors. Plazmic is recognized for its innovative contributions to rich-media graphics in the mobile sector.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

Nu-Wave Photonics is a manufacturer of optical sensors for detecting chemicals and biological agents.

Chancery Software is a leading provider of student information management solutions tailored for K-12 schools and districts. With over 15 years of industry experience, the company offers software tools designed to assist in the management of critical student information, including enrollments, scheduling, attendance, grading, and performance tracking. Chancery's solutions deliver accurate, real-time data on more than thirteen million students to one million educators daily, helping schools navigate the complexities of educational administration. The company has achieved over 18,000 installations across North America, customizing its offerings to meet the diverse needs and budgets of various educational institutions. Chancery Software is recognized as a trusted partner in the educational community, particularly in alignment with regulatory requirements such as the No Child Left Behind Act.

Knowledge Junction Systems develops and markets Business Intelligence and Smart e-Commerce Applications.

Prologic Corporation is the leading developer of software solutions for the global financial services industry. Their technologies enable financial institutions to quickly deploy solutions for their converging financial services offerings, while also supporting capabilities for increasing profitability, customer acquisition and retention. Through strategic alliances with Microsoft, Compaq Computer Corporation, EDS, Siemens Business Services, CAP Gemini, NRI, CGI, ISM-BC, APAK Systems and other international partners, Prologic’s financial solutions are in use in over 300 financial institutions globally. More than 20 Internet banks use Prologic solutions. 7 of the top 25 largest banks in the world use Prologic products.

Sedona Networks designs and builds innovative, multi-services access network solutions.